Skip to content
Open access · CC-BY via OpenAlex

Complement system and age-related macular degeneration: drugs and challenges

Jiali Wu, Xiaodong Sun

Drug Design Development and Therapy · 2019 · ▲ 81 citations

Abstract

Abstract: Age-related macular degeneration (AMD) is directly attributable to vision loss, posing significant pressure on public health. AMD is recognized to be a multi-factorial disease and among them, complement system is under heated discussion in recent years. In this review, we start with an overview of complement pathways involved in AMD and their therapies correspondingly. Finally, we discuss the development of the therapeutics existed now. Also, we enclose a list of drugs undergoing clinical trials. Keywords: age-related macular degeneration, inflammation, complement system, immunotherapy

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.2147/dddt.s206355
Canonical
link ↗
Fetched
2026-10-20 MST

Cite this

APA
Wu, J., &amp; Sun, X. (2019). Complement system and age-related macular degeneration: drugs and challenges. <em>Drug Design Development and Therapy</em>. https://doi.org/10.2147/dddt.s206355
Vancouver
Wu J, Sun X. Complement system and age-related macular degeneration: drugs and challenges. Drug Design Development and Therapy. 2019. doi:10.2147/dddt.s206355.
BibTeX
@article{jiali2019Comple, title = {Complement system and age-related macular degeneration: drugs and challenges}, author = {Jiali Wu and Xiaodong Sun}, journal = {Drug Design Development and Therapy}, year = {2019}, doi = {10.2147/dddt.s206355}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings